Uncategorized 6/14/13 Uncategorized 6/14/13 Just a Few More Things for FDA to Focus on Read More Advocacy at a Glance 6/14/13 Advocacy at a Glance 6/14/13 Animal Drug and Animal Generic Drug User Fee Reauthorization Act Signed into Law and more Read More Uncategorized 6/9/13 Uncategorized 6/9/13 Full Committee Mark-up of House Appropriations Bill This Thursday Read More Uncategorized 6/7/13 Uncategorized 6/7/13 House Exceptionalizes FDA for FY 14 ... But More Needed Read More Advocacy at a Glance 6/7/13 Advocacy at a Glance 6/7/13 Congressional Efforts Continue on User Fees and Sequester and more Read More Uncategorized 6/4/13 Uncategorized 6/4/13 Alliance Praises Prioritization of FDA in FY 14 Appropriations Process Read More Uncategorized 5/31/13 Uncategorized 5/31/13 What Authorizers and Appropriators Are Doing -- The Disconnect Read More Advocacy at a Glance 5/31/13 Advocacy at a Glance 5/31/13 Alliance’s New FDA Budget Primer Attached and more Read More Uncategorized 5/24/13 Uncategorized 5/24/13 And the Mailbox is Still Filling Up ... Read More Advocacy at a Glance 5/24/13 Advocacy at a Glance 5/24/13 Lawmakers Explore Sequester Flexibility Plans and more Read More Advocacy at a Glance 5/17/13 Advocacy at a Glance 5/17/13 House releases its 302(b) allocations for FY 14 appropriations and more Read More Uncategorized 5/17/13 Uncategorized 5/17/13 Another Look into the Mailbox in Silver Spring Read More Uncategorized 5/10/13 Uncategorized 5/10/13 More From Steven Grossman's Mailbox Read More Advocacy at a Glance 5/10/13 Advocacy at a Glance 5/10/13 Latest on Congressional Timing and more Read More Uncategorized 5/9/13 Uncategorized 5/9/13 Alliance's Ladd Wiley Interviewed by ACRO Read More Uncategorized 5/3/13 Uncategorized 5/3/13 The Implications of the BCA on FDA Funding Read More Advocacy at a Glance 5/3/13 Advocacy at a Glance 5/3/13 Quarterly Alliance Member Meeting and more Read More Uncategorized 4/26/13 Uncategorized 4/26/13 Helping the Media to "Tell It Like It Is" Read More Advocacy at a Glance 4/26/13 Advocacy at a Glance 4/26/13 Freshman/Sophomore FDA Hill Meetings, May 1 and May 2 and more Read More Uncategorized 4/19/13 Uncategorized 4/19/13 Alliance Formulates FY 14 Budget Request for FDA Read More Newer Posts Older Posts
Advocacy at a Glance 6/14/13 Advocacy at a Glance 6/14/13 Animal Drug and Animal Generic Drug User Fee Reauthorization Act Signed into Law and more Read More
Uncategorized 6/9/13 Uncategorized 6/9/13 Full Committee Mark-up of House Appropriations Bill This Thursday Read More
Uncategorized 6/7/13 Uncategorized 6/7/13 House Exceptionalizes FDA for FY 14 ... But More Needed Read More
Advocacy at a Glance 6/7/13 Advocacy at a Glance 6/7/13 Congressional Efforts Continue on User Fees and Sequester and more Read More
Uncategorized 6/4/13 Uncategorized 6/4/13 Alliance Praises Prioritization of FDA in FY 14 Appropriations Process Read More
Uncategorized 5/31/13 Uncategorized 5/31/13 What Authorizers and Appropriators Are Doing -- The Disconnect Read More
Advocacy at a Glance 5/31/13 Advocacy at a Glance 5/31/13 Alliance’s New FDA Budget Primer Attached and more Read More
Advocacy at a Glance 5/24/13 Advocacy at a Glance 5/24/13 Lawmakers Explore Sequester Flexibility Plans and more Read More
Advocacy at a Glance 5/17/13 Advocacy at a Glance 5/17/13 House releases its 302(b) allocations for FY 14 appropriations and more Read More
Advocacy at a Glance 5/10/13 Advocacy at a Glance 5/10/13 Latest on Congressional Timing and more Read More
Advocacy at a Glance 5/3/13 Advocacy at a Glance 5/3/13 Quarterly Alliance Member Meeting and more Read More
Advocacy at a Glance 4/26/13 Advocacy at a Glance 4/26/13 Freshman/Sophomore FDA Hill Meetings, May 1 and May 2 and more Read More
Uncategorized 4/19/13 Uncategorized 4/19/13 Alliance Formulates FY 14 Budget Request for FDA Read More
